论文信息 - PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy - 字舞流文

PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy

J. Park | E. Lee | Shin‐Yup Lee | J. Choi | S. Cha | J. Jeong | K. Shin | S. Yoo | Jaehee Lee | W. Lee | Hyo‐Gyoung Kang | M. Hong | S. K. Do | C. Jin | Y. Seok | C. Kim | D. K. Jung | Hyo-Gyoung Kang